Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.10
Delayed Data
As of May 26
 -0.09 / -2.15%
Today’s Change
3.26
Today|||52-Week Range
6.59
+18.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues12.7M27.6M81.4M37.0M
 
 
 
 
 
Cost of Goods Sold8.1M3.7M2.1M3.2M
 
 
 
 
 
Depreciation And Amortization11.1M9.7M8.2M9.2M
 
 
 
 
 
 
Operating ExpensesGross Income-6.5M14.2M71.1M24.6M
 
 
 
 
 
General Expenses72.8M71.3M94.0M129.9M
 
 
 
 
 
Research And Development58.7M54.1M66.5M100.3M
 
 
 
 
 
Total Operating Expenses92.1M84.7M104.3M142.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-79.3M-57.1M-22.9M-105.3M
 
 
 
 
 
Extraordinary Credit47.0K0.0010.2M4.4M
 
 
 
 
Extraordinary Charge-14.0M-19.8M0.000.00
 
 
 
Interest Expense On Debt14.3M9.1M7.1M6.9M
 
 
 
 
 
Other Expenses-1.8M400.0K352.0K47.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-109.2M-85.5M-19.4M-60.5M
 
 
 
 
 
Preferred Dividend-2.3M-2.8M0.000.00
 
 
 
Net Income-109.2M-85.5M-19.4M-60.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.2M196.5M218.1M219.7M
 
 
 
 
 
Shares To Calculate EPS Diluted139.2M196.5M218.1M219.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$0.45-$0.09-$0.28
 
 
 
 
 
EPS Diluted-$0.80-$0.45-$0.09-$0.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account